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Abstract
Naphthalene is an environmental toxicant to which humans are exposed. Naphthalene
causes dose-dependent cytotoxicity to murine airway epithelial cells but a link between ex-
posure and human pulmonary disease has not been established. Naphthalene toxicity in ro-
dents depends on P450 metabolism. Subsequent biotransformation results in urinary
elimination of several conjugated metabolites. Glucuronide and sulfate conjugates of naph-
thols have been used as markers of naphthalene exposure but, as the current studies dem-
onstrate, these assays provide a limited view of the range of metabolites generated from the
parent hydrocarbon. Here, we present a liquid chromatography tandem mass spectrometry
method for measurement of the glucuronide and sulfate conjugates of 1-naphthol as well as
the mercapturic acids and N-acetyl glutathione conjugates from naphthalene epoxide. Stan-
dard curves were linear over 2 log orders. On column detection limits varied from 0.91 to 3.4
ng; limits of quantitation from 1.8 to 6.4 ng. The accuracy of measurement of spiked urine
standards was -13.1 to + 5.2% of target and intra-day and inter-day variability averaged 7.2
(± 4.5) and 6.8 (± 5.0) %, respectively. Application of the method to urine collected from
mice exposed to naphthalene at 15 ppm (4 hrs) showed that glutathione-derived metabo-
lites accounted for 60-70% of the total measured metabolites and sulfate and glucuronide
conjugates were eliminated in equal amounts. The method is robust and directly measures
several major naphthalene metabolites including those derived from glutathione conjuga-
tion of naphthalene epoxide. The assays do not require enzymatic deconjugation, extraction
or derivatization thus simplifying sample work up.
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Introduction
The incidence of lung disease including asthma and chronic obstructive pulmonary disease
(COPD) has increased dramatically in the past 20 years and substantial evidence supports a
role for vehicle emissions as a factor in the etiology of these diseases [1]. Vehicle emissions are
a complex mixture containing a number of entities including polycyclic aromatic hydrocar-
bons, the most abundant of which are naphthalene and various methylnaphthalene derivatives
[2].
Naphthalene is a volatile, lipid soluble polyaromatic hydrocarbon and an important compo-
nent of various fossil fuels, cigarette smoke, and jet fuel (1–3% by weight) [3,4]. The finding
that a number of low molecular weight polycyclic hydrocarbons such as naphthalene cause
acute toxicity in lungs of mice raises the possibility that environmental exposures to these
chemicals could pose a human health concern. Previous studies demonstrated that dose-de-
pendent airway epithelial Clara cell (target cell) cytotoxicity due to naphthalene inhalation cor-
relates strongly with high rates of metabolic activation by abundant, localized cytochrome
P450 monooxygenases [5].
Several sensitive gas chromatography and gas chromatography-mass spectrometry methods
have been developed as a means to effectively assess internal naphthalene exposures in indus-
trial workers through detection of excreted naphthols [6,7]. Furthermore, in the NHANES
(National Health and Nutrition Exposure Study) study Li and coworkers found detectable lev-
els of urinary 1- and 2-naphthols in nearly the entire experimental cohort (general population,
non-occupationally exposed) by GC-MS [8]. While excreted naphthols indicate naphthalene
exposure and metabolism through the epoxide (Fig 1A), they underestimate the total amount
of epoxide formed because they do not account for metabolites derived through the glutathione
pathway. In vitro studies using human liver microsomes in the absence of glutathione and the
GSH transferases demonstrated that the rates of dihydrodiol formation greatly exceed those of
1-naphthol [9]. In animal models, a significant proportion of urinary naphthalene metabolites
are derived from the glutathione conjugates (Fig 1A) [10,11]. Yet, downstream metabolites of
the glutathione adduct (mercapturic acids) have only been reported in humans using urine
spot tests on paper chromatograms from individuals given large (500 mg p.o., approximately
1.4 mg/kg) doses of naphthalene [12]. Interestingly, other work in non-human primates failed
to detect mercapturic acids of naphthalene but the reliability of this assay is uncertain because
standards were not available [13]. In addition, an important consideration when using urinary
naphthols to assess naphthalene exposure is that 1-naphthol excretion is also indicative of ex-
posure to the insecticide, carbaryl [14]. Thus, there is a need to develop and validate quantita-
tive methods for accurately measuring a range of naphthalene metabolites including the
mercapturic acids, sulfate and glucuronide derivatives of naphthol, dihydrodiol, and any conju-
gates arising from naphthoquinones and the diol epoxide.
While many human exposure studies, including the NHANES assessments, have measured
glucuronide and sulfate metabolites derived from naphthols in urine, very little attention has
been given to other metabolites derived directly from the 1, 2-epoxide [15,16]. The work de-
scribed here tested the hypothesis that the mercapturic acids and N-acetyl glutathione conju-
gates (N-acetyl GSH) formed from naphthalene oxide are quantitatively more important
metabolites in mice than are the conjugates derived from naphthols. Since the glutathione-de-
rived metabolites of naphthalene cannot arise from carbaryl, these metabolites may serve as
better biomarkers of exposure to naphthalene than the naphthol-derived sulfate or glucuronide
conjugates. Due to the highly polar nature of these conjugated metabolites as well as limited
commercial availability of authentic standards, simultaneous quantification of multiple urinary
metabolite targets presents a complex challenge. The availability of electrospray ionization
LC/MS/MSMeasurement of Naphthalene Conjugates
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(ESI) for mass spectrometry has allowed for development of both sensitive and specific LC-MS
methods for a variety of compounds particularly for highly polar compounds that are not ame-
nable to GC-MS analysis. Measurement of conjugates directly rather than after chemical or en-
zymatic hydrolysis decreases the time and complexity of analysis and allows separate
measurements of sulfate, glucuronide and glutathione-derived naphthalene metabolites.
Accordingly, we developed a sensitive, robust LC-MS/MS method for the quantification of
four major urinary naphthalene metabolites (Fig 1B). As proof of principle, we used the vali-
dated method to assess changes in the urinary metabolite profile in mice subjected to daily ex-
posures to naphthalene at the OSHA short-term exposure limit (15ppm).
Fig 1. Overview of naphthalene metabolism and excretion. (A) Naphthalene metabolism showing the formation of both naphthol- and glutathione-derived
urinary metabolites. (B) Chemical structures of targeted urinary naphthalene metabolites for LC/ESI-MS/MS analysis.
doi:10.1371/journal.pone.0121937.g001
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Materials and Methods
Animals
All animal work was conducted under protocols approved by the University of California—
Davis Animal Use and Care Committee (PHS/NIH Assurance (A3433-01). Male Swiss-Web-
ster mice (25-30g) were purchased from Harlan (San Diego, CA) and allowed free access to
food and water. Animals were housed in HEPA-filtered isolators in an AAALAC accredited fa-
cility for at least one week before use.
Chemicals and reagents
Naphthalene (scintillation grade) was purchased from Fisher Scientific (Waltham, MA). Deu-
terium-labeled naphthalene (d-8-99%) was purchased from Isotech through Sigma-Aldrich
(Milwaukee, WI). N-Acetyl cysteine and glutathione were purchased from Sigma (St Louis.
MO). All mobile phase solvents and solvents used to dilute samples were Optima grade pur-
chased from Fisher Scientific (Waltham, MA). All other chemicals were reagent grade or better
and purchased from Fisher Scientific (Waltham, MA).
Naphthalene metabolite standards
Naphthol derivatives (1-naphthol-β-D-glucuronic acid and 1-naphthol sulfate) were obtained
commercially (Carbosynth, San Bruno, CA and Research Organics, Cleveland, OH, respective-
ly). 2-Naphthol glucuronide was prepared synthetically by oxidation of 2-naphthyl-β-D-glyco-
pyranoside (Carbosynth) with 2,2’,6,6’-tetramethylpiperidine-1-oxyl (TEMPO, Sigma). The
product was purified by semi preparative LC. 1,2-Naphthalene epoxides were synthesized as
previously described [17]. Naphthalene mercapturic acid isomers were synthesized as follows:
racemic naphthalene oxide (0.15–0.25 M) in ethanol was added drop wise with stirring to a 5
molar excess solution of N-acetyl cysteine dissolved in argon-sparged 0.1 M phosphate buffer
at pH 8.5. The reaction mixture was stirred under argon for 4 h. The mixture was extracted
with ether. The ether layer was discarded and the water layer partially evaporated to remove re-
sidual ether. The solution was acidified with acetic acid to pH 3, desalted using a SM-16 sty-
rene-divinyl-benzene solid phase extraction cartridge (Biorad, Richmond CA), neutralized by
the drop wise addition of pyridine, and lyophilized to dryness. The residue was reconstituted in
25% acetonitrile/water and purified by HPLC.
The N-acetyl glutathione conjugate of naphthalene was synthesized using the naphthalene
glutathione conjugate. The glutathione conjugate (0.25 mmoles) was dissolved in 50 mL of
argon sparged 0.1M Na2HPO4 buffer pH 8.5. The pH was carefully adjusted to pH 8.0 followed
by the addition of 1 mmole Sulfo-NHS Acetate (Thermo Fisher/Pierce, WalthamMA), dis-
solved in nanopure water and added in one portion. The pH was immediately readjusted to pH
8.0. The reaction was allowed to proceed for 3 hours under argon. The reaction was then acidi-
fied to pH 3 with formic acid and applied to a SM-16 styrene-divinyl-benzene solid phase ex-
traction cartridge (Biorad, Richmond CA) pre-equilibrated with 0.5% formic acid/water, and
washed with 50 column volumes of 0.5% formic acid/water. The cartridge was then eluted with
25% acetonitrile and the eluent monitored at 254nm. The UV absorbing peak was collected
and immediately neutralized to pH 6–7 with NH4OH. The solution was then lyophilized to
dryness for 72 hrs under high vacuum to evaporate excess ammonium formate. The residue
was dissolved in 25% acetonitrile/water and purified by preparative HPLC.
Purification of all synthetic metabolites was done by preparative HPLC using a 0.5% for-
mic acid water/acetonitrile gradient system on a Phenomonex Sphericlone ODS2 column
(5 μ, 22 x 250 mm) (Torrance CA). The HPLC purified peak was neutralized with pyridine
LC/MS/MSMeasurement of Naphthalene Conjugates
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and lyophilized. Samples were reconstituted as needed in 5% acetonitrile. Purity was as-
sessed by LC-MS on a Thermo LCQ Advantage ion trap mass spectrometer (Thermo Fisher
Scientific, San Jose CA). Metabolites were less stable in solution than as a powder and multi-
ple freeze-thaw cycles of solubilized metabolites should be avoided.
Internal standards
Deuterium-labeled naphthalene metabolites were prepared biosynthetically by treating mice
with d-8 labeled naphthalene at relatively high doses and collecting the urine for use as a mix-
ture of 99% d-8 labeled metabolites. Identical quantities of urine containing the d-8 metabolites
were added directly to each of the unlabeled standards to generate standard curves and to urine
from naphthalene-exposed animals to act as an internal standard for quantification of metabo-
lites. Briefly, male Swiss-Webster mice (n = 4, body weight: 27.8–30.1 g) were placed (4 per
cage) in glass metabolism cages (BioServe Biotechnologies, Laurel MD). The animals were
dosed using a solution of 40 mg/ml 99% deuterium-labeled (d-8) naphthalene (dissolved in
oleic oil) which was administered intraperitoneally at 0.05 ml/10 grams body weight (total dose
of 200 mg/kg). The 24-hour urine was collected over dry ice. The urine was transferred to a
clean Teflon tube and weighed to determine volume. An additional 2 volumes of acetonitrile
were added to the urine and samples were stored at -20° C overnight. The next day, the urine
was centrifuged at 9500g for 15min at 5°C. The supernatant was transferred to a Teflon bottle
and lyophilized to dryness. The urine was reconstituted in 5% acetonitrile to the original urine
volume, aliquoted and placed in storage at- 80º C. Metabolites in the urine samples dehydrate
in acidic environments.
Instrumentation
Composite urine samples (10 μl) were analyzed using aWaters 2795 Separations Module (Waters
Corporation, Milford, MA). Naphthalene metabolite separation was carried out on a 2.1 x 150mm,
2.6μmKinetex XB-C18 column (Phenomenex, Torrance CA) protected by a 2.1 x 2.0 mmC-18
SecurityGuard Ultra cartridge system (Phenomenex, Torrance, CA) maintained at a temperature
of 35°C. The mobile phases were 0.1% acetic acid in H2O (A) and 0.1% acetic acid in 50% acetoni-
trile/water (v/v) (B). At a flow rate of 0.210 ml/min, initial conditions (90% A/ 10% B) were held
isocratic for 14 min. Mobile phase B was increased by 5% (85% A/15% B) for 1 min followed by a
linear gradient to 77% A/ 23% B at 65 min. Then mobile phase B was increased to 100% in 5 min.
These conditions were held isocratic for 10 min (to 80 min). Finally, the mobile phase was re-
turned to initial conditions (90% A/10% B) in 5 min. The column was allowed to re-equilibrate
for 15 min. Total run time for each sample was 100 min.
MS/MS data were acquired using negative mode electrospray ionization (ESI-) on a Thermo
LCQ Advantage ion trap mass spectrometer. TandemMS parameters were optimized for all
four metabolites (Table 1). While each metabolite had its own specific ion trap parameters and
collision energies, the ESI source parameters were held constant throughout data acquisition.
The optimized parameters for the ESI source were: source voltage set to 4.5 kV, capillary tem-
perature at 250º C, nitrogen sheath and auxiliary gases at 40 and 10 (arbitrary units), respec-
tively. Automatic gain control (AGC) was used to prevent accumulation of excess charge in the
ion trap and maximum ion injection time was set to 200 ms during data acquisition. The trap
was set to average three microscans during all targeted full-scan MS/MS acquisitions.
Each metabolite had its own deuterium-labeled internal standard except for N-acetyl GSH,
which was quantified using the internal standard for mercapturic acid. M/Z for the internal
standard derived from naphthalene oxide (mercapturic acid conjugate) was +8 while those
from naphthol (glucuronide and sulfate) were +7 AMU. Metabolite and internal standard
LC/MS/MSMeasurement of Naphthalene Conjugates
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peaks were identified by extracting targeted compound-specific fragment masses (m/z) from
the total ion chromatogram (TIC) at the expected retention times. Thermo Xcalibur 2.0.7 soft-
ware was used to control instrumentation and acquire raw MS data.
Sample preparation
From each composite urine sample (pooled urine from three mice), 10 μl were transferred to a
0.5 mL microcentrifuge tube. Ten microliters of urine containing d-8 labeled metabolites (in-
ternal standard) were added in addition to 2 volumes (40μl) of Optima-grade acetonitrile. Sam-
ples were placed in the freezer at—80°C overnight. Samples were then thawed and diluted to
200 μl with 140 μl of 5% Optima grade acetonitrile/water. The samples were centrifuged at
16,000g for 30 min held at 4°C and the supernatant was transferred to an autosampler vial. A
total of 10 μl of each sample was injected on column for LC-MS/MS analysis.
Preparation of calibration and quality control (QC) standards
Stock solutions of all four metabolites were prepared by weighing and dissolving the com-
pounds in 5% acetonitrile/water. These stock solutions were diluted further to prepare appro-
priate calibration and QC standards for analysis. Calibration standards were prepared by
adding appropriate amounts of each metabolite solution into blank pooled urine taken from
naïve mice. Final concentrations were 0.5, 1.0, 2.5, 5.0, 10.0, 25.0, and 50.0 μg/ml of urine for
the mercapturic acid and 0.1, 0.25, 0.50, 1.0, 2.5, 5.0, and 10.0 μg/ml of urine injected for the N-
acetyl GSH, naphthol glucuronide and sulfate.
For method validation, three QC standards (1.0, 4.0, 7.0 μg/ml for the mercapturic acid and
0.5, 2.0, 7.0 μg/ml for all other metabolites) were prepared by adding appropriate amounts of
metabolite standard solutions into blank urine. Each calibration and QC standard contained
differing amounts of each metabolite to closely mimic the natural variation found in urinary
metabolite concentration during exposure experiments. All calibration and QC standards were
prepared for LC-MS/MS analysis as described above.
Specificity, sensitivity, and linearity
Specificity of the method was assessed by analyzing multiple blank pooled urine samples with
the same LC-MS/MS parameters to ensure lack of mass signal in the same retention window as
targeted metabolites or internal standards. The method limit of detection was estimated by
multiplying the standard deviation of seven replicate measurements of the lowest QC standard
Table 1. Parameters for LC/ESI-MS/MS analysis of urinary naphthalene metabolites and internal standards (IS).
Metabolite Retention time (min) Molecular Ion (m/z)a MS/MS fragments (m/z)b CEc(%)
Mercapturic Acid 41.5 306 159, 288 45
N-Acetyl GSH 42.7 492 296, 314 42
Naphthol Glucuronide 68.4 319 113, 143, 175 32
Naphthol Sulfate 74.4 223 80, 143 32
d8-Mercapturic Acid (IS) 38.9 314 166, 295 45
d7-Naphthol Glucuronide 65.4 326 113,150,175 32
d7-Naphthol Sulfate 74.1 230 80, 150 32
a Molecular ion, [M-H]-, acquired in negative ion ESI.
bTo increase signal, product ion intensities were summed for quantification.
cCollision energy used to produce product ions.
doi:10.1371/journal.pone.0121937.t001
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by the Student’s t-value 3.143 (99% confidence level for seven replicates) for each metabolite.
The method quantification limit was calculated as 10 times the standard deviation of the seven
replicate measurements. Linearity of the method was assessed by plotting the peak area ratio of
each metabolite/deuterated metabolite against the concentration spiked into control urine. The
correlation between the peak area ratio and metabolite concentration was determined by least
squares linear regression models. A full set of seven calibration standards were run in random
order on four separate days to ensure that the method was robust and linear.
Accuracy and Precision
Accuracy of the method was determined by calculating the percent bias observed in the repli-
cate analysis of QC standards at three concentrations (n = 4 measurements) for each metabo-
lite. Intra-day precision was determined by analyzing the three QC standards in triplicate
(n = 3) during the same day and calculating the respective percent relative standard deviation
(%RSD). Inter-day precision was expressed as the resulting %RSD from analyzing the three
QC standards on four separate days. Due to the length of time between sample analyses, long-
term autosampler stabilities of each naphthalene metabolite and respective deuterated internal
standards were evaluated. This was done by analyzing calibration standard 3 (mercapturic
acid, N-acetyl GSH, naphthol glucuronide, naphthol sulfate at 50.0, 10.0, 5.0, 1.0 μg/ml of
urine injected, respectively) a total of five times over 63 hours and evaluating the percent bias
and %RSD.
Matrix effect evaluation and sample preparation recovery
To evaluate absolute matrix effect of the urine, duplicate sets of three QC standards (high, me-
dium, low levels) were made up in solvent and in blank urine extract. The duplicate sets were
analyzed in triplicate and area counts of each naphthalene metabolite were compared with the
formula: Matrix Effect (%) = [Area counts (spiked urine))/Area counts (spiked solvent)]100
[18]. Recovery of the entire sample preparation (precipitation and dilution) was characterized
by analyzing duplicate sets of standard solutions (125 ng injected on column for the mercaptu-
ric acid, and 25 ng injected on column for all other metabolites) made up in both crude urine
which was later extracted and post-extracted urine in triplicate. Ten microliters of internal
standard urine was added to both sets of samples to test the suitability of the deuterium-labeled
naphthalene metabolites for quantification. Calculated amounts per 10 μl injected were com-
pared for each metabolite.
Animal treatments and sample collection
Practical application of the method was determined by analyzing pooled urine samples from
mice subjected to daily naphthalene exposures at levels relevant to human exposure limits. Ani-
mals were exposed to naphthalene vapors by inhalation in glass metabolism cages as described
in detail previously [11,19]. Briefly, naphthalene vapors were generated by passing filtered,
compressed air through a column containing crystalline naphthalene. This was mixed with
compressed air in a mixing chamber; concentrations were monitored continuously by passing
the samples through a UV flow cell monitored at a wavelength of 210 nm. Two groups of mice
(3 per cage) were exposed to 15 ppm naphthalene for 4 hrs for 7 consecutive days. All expo-
sures were concluded before 1 pm to avoid differences associated with the diurnal variations in
glutathione levels. Following exposure, mice were transferred to a clean metabolism cage. All
urine collection vessels were kept on dry ice so that urine was frozen immediately. Urine from
the two groups of mice was collected at 24 hr intervals for a period of 7 days for a total of twelve
composite samples (n = 2 samples for each day). As a control, two groups of three mice were
LC/MS/MSMeasurement of Naphthalene Conjugates
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exposed to filtered air for a total of seven days (n = 2 samples each day, 12 total samples). Urine
was collected in the same way as from exposed animals. These samples were prepared for anal-
ysis as described in Section 2.5.
Data analysis
To obtain the most meaningful urinary metabolite comparisons, calculated metabolite
amounts per 10 μl injected on column were normalized against daily volumetric urine output
and molecular mass resulting in nmoles of metabolite excreted per day. Daily urine output was
determined gravimetrically using 1.00 as the estimated composite urine density. All statistical
and data analyses were performed on Microsoft Excel 2010 and SigmaPlot ver. 11.
Results
Liquid chromatography mass spectrometry (LC-MS/MS)
We achieved optimal separation of all four major naphthalene metabolites and their corre-
sponding deuterium-labeled internal standards with a 0.1% acetic acid water/acetonitrile gradi-
ent. All targeted metabolites eluted between 38.9 and 74.4 min (Table 1). Strong signals were
observed for all metabolite-specific MS/MS fragments under all conditions tested. Fig 2 shows
representative extracted ion chromatograms (EIC) of both a QC standard and typical compos-
ite urine sample from mice exposed to naphthalene. Two other metabolites were successfully
separated, and were tentatively identified as the mercapturic acid conjugate derived from the
dihydrodiol epoxide and dihydroxynaphthalene diglucuronide based on molecular ion (m/z)
values 340 and 511, respectively (data not shown). Both were verified by high resolution
mass spectrometry.
Authentic metabolite standards were not available so product ion spectra could not be com-
pared, and accurate quantification could not be achieved.
Specificity, sensitivity, and linearity
All analyzed matrix blanks (control urine from unexposed mice, n = 10) resulted in signals
lower than the limit of detection for each metabolite and internal standard (S1A Fig). The
method detection and quantification limits ranged from 0.9 to 3.4 and 2.9 to 10.8 ng on col-
umn, respectively (Table 2). We found that the estimated values were in general agreement
with empirical values resulting from the lowest QC standards, except for the naphthol glucuro-
nide. Our method reproducibly determined 5 ng injected on column (lowest QC) which is
lower than the estimated method LOQ. S2A and S3A Figs. shows a representative chromato-
gram of each metabolite at the lowest QC level. Excellent, reproducible linearity (R2 range:
0.9930–0.9989) was achieved for the metabolite calibration ranges (Table 2). There were some
unacceptable percent bias values from the lowest calibration standards (below the lowest QC
levels) for each metabolite which was expected due to our estimated method LOD and
LOQ values.
Accuracy and precision
Accuracy and precision of the analyzed QC standards are shown in Table 3. Percent biases
were all within ±15%, the intra-day and inter-day were within acceptable limits of 20% for all
concentrations analyzed. The percent bias and percent RSD of the long-term autosampler sta-
bility study of calibration standard 3 ranged from 0.04–4.2% and 2.4–3.8% for all metabolites,
respectively.
LC/MS/MSMeasurement of Naphthalene Conjugates
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Matrix effect evaluation and sample preparation recovery
Calculated absolute matrix effects were between -16.8 to 11.8% for each metabolite at all con-
centrations analyzed (data not shown). The optimized urine sample preparation recoveries
ranged from 86–101.6%.
Fig 2. Extracted ion chromatograms of urinary naphthalenemetabolites and deuterated internal standards. (A) QC Sample #2. Naphthalene
mercapturate, N-acetyl glutathione conjugate, naphthol glucuronide, and naphthol sulfate at 40, 5, 70, 20 ng on column, respectively. (B) Pooled urine
sample from day 6–7 of exposure treatments (n = 3 animals). Calculated amounts of each metabolite on column were: 124.8, 7.9, 45.3, 25.9 ng for
mercapturic acid, N-acetyl GSH, naphthol glucuronide and naphthol sulfate, respectively.
doi:10.1371/journal.pone.0121937.g002
Table 2. Estimated limits of detection (LOD), quantification (LOQ), and linearity of LC-MS/MSmethod for urinary naphthalene metabolite analysis.
Metabolite LOD (ng/10μl injected) LOQ (ng/10μl injected) Linearity
Range (ng/10μl injected) Correlation Coefficient (R2)a
Mercapturic Acid 3.40 6.79 5–500 0.9989
N-Acetyl GSH 1.29 2.58 1–100 0.9930
Naphthol Glucuronide 2.30 4.60 1–100 0.9973
Naphthol Sulfate 0.91 1.82 1–100 0.9940
a Average correlation coefficient (n = 5 calibration curves)
doi:10.1371/journal.pone.0121937.t002
LC/MS/MSMeasurement of Naphthalene Conjugates
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Method application
The entire experimental cohort (2 groups of 3 mice) produced daily urine samples which all
contained detectable levels of all four targeted naphthalene metabolites. All control animal
urine samples had levels below the method LOD. Fig 3A shows an overall increase in glutathi-
one-derived metabolite (mercapturic acid, N-acetyl GSH) excretion over the entire exposure
experiment. The mercapturic acid ranged from 139.5–263.5 nmoles excreted/24 hrs and repre-
sented, on average, greater than 60% of the total amount of quantified metabolites in each daily
urine sample (range: 57.2–67.2%) (Fig 4). Over the 7 days, N-acetyl GSH steadily increased
from 2.1 to 12.3 nmoles and represented an average 1–3% (range: 0.9–3.3%) contribution of
total metabolite amount excreted (Fig 4).
The amounts of excreted naphthol glucuronide and naphthol sulfate ranged from 31.6–64.4
and 35.8–65.8 nmoles/24 hrs, respectively. Although the amounts of naphthol metabolites in-
creased slightly over the 7 days of exposure (Fig 3B) with glucuronide and sulfate increasing by
12 and 19% on day 7 when compared to day 1, their percent contributions to total metabolite
amounts fell slightly from 19.6 to 15.4% for naphthol glucuronide and 18.7 to 15.5% for naph-
thol sulfate (ranges: 21.5 to 14.6% and 20.8 to 15% for naphthol glucuronide and naphthol sul-
fate, respectively) (Fig 4). The amounts of glutathione- derived metabolites eliminated on day 7
were considerably greater than on day 1; the elimination of mercapturic acid and N-acetyl
GSH increased by 57 and 213%, respectively (Fig 3A and 3B).
Fig 3C shows a decrease in total metabolite excretion during the second and third day with
a subsequent sharp increase thereafter. This correlates well with the observed decrease in water
and food intake and urinary output of both exposed groups observed during the second and
third days of the exposure experiments (data not shown). Average total quantified naphthalene
metabolites ranged from 178.5 nmoles during day 3 to up to 400 nmoles on the final day
of exposure.
Table 3. Accuracy and precision results of quality control standards.
Metabolite QC
Standard
Nominal Amount (ng/10μl
injected)
Determined Amount (ng/10μl
injected)a
Accuracy (%
bias)
Relative Standard Deviation
(%RSD)
Intra-day
(n = 3)
Interday
(n = 4)
Mercapturic Acid 1 10.00 10.09 0.86 5.38 10.33
2 40.00 41.25 3.13 5.20 16.15
3 70.00 66.52 -4.97 16.87 6.08
N-Acetyl GSH 1 70.00 65.88 -5.88 8.58 1.32
2 5.00 4.86 -2.84 10.14 4.58
3 20.00 20.28 1.42 5.76 2.92
Naphthol
Glucuronide
1 20.00 17.39 -13.07 2.59 7.48
2 70.00 73.66 5.23 8.72 7.99
3 5.00 4.65 -7.09 12.39 15.47
Naphthol Sulfate 1 70.00 70.84 1.20 3.54 0.77
2 20.00 20.84 4.22 0.50 2.93
3 5.00 4.54 -9.21 7.11 5.59
a Average determined amount (n = 4)
doi:10.1371/journal.pone.0121937.t003
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Discussion
We present here a robust LC-ion trap tandem mass spectrometry method for the measurement
of four major naphthalene metabolites in the urine of mice exposed to this PAH at levels rele-
vant to human occupational exposure (15 ppm, OSHA STEL). The method shows good repro-
ducibility and accuracy, and in comparison to the GC/MS methods for measuring 1- and
2-naphthol conjugates requires minimal sample cleanup [8]. The GC/MS methods for measur-
ing naphthol conjugates entail hydrolysis, extraction, and derivative formation [20]. In addi-
tion, we were capable of differentiating metabolites which are rearrangement products of
naphthalene oxide (glucuronide and sulfate derivatives of 1-naphthol) versus those generated
by direct glutathione conjugation of the epoxide and excreted as mercapturic acids or as a
Fig 3. Urinary excretion of major naphthalenemetabolites during repeated naphthalene exposure at the OSHA short-term exposure limit (15ppm x
4 hrs daily) via inhalation. (A) Average glutathione-derived metabolites excreted over entire exposure treatment (n = 2). (B) Average naphthol-derived
metabolites excreted over entire exposure treatment (n = 2) (C) Total nmoles of quantified metabolite excreted over entire exposure treatment (n = 2). In all
cases data represent the total nmoles of each metabolite excreted in a 24 hr period (ie concentration of metabolite (nmoles/ml) x mls urine collected for
24 hrs). Values are the mean of data obtained from 2 separate exposures (n = 2 cages) with 3 mice per cage.
doi:10.1371/journal.pone.0121937.g003
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novel N-acetyl glutathione derivative [21]. Conjugation with glutathione is one of the primary
protective mechanisms against naphthalene cytotoxicity in animals [22] and, like other chemi-
cals that undergo metabolic activation to generate soft electrophiles, naphthalene shows a glu-
tathione threshold. Significant cytotoxicity and covalent protein adduct formation does not
occur until glutathione is depleted substantially (20% of control GSH level) [22].
Although the 3D ion trap mass spectrometer has been used in the past as a quantitative de-
tector [23,24], and under carefully controlled conditions can yield data that are comparable to
a triple quadropole instrument [24], lack of sensitivity and relatively long chromatographic
runs necessary to separate metabolites are distinct disadvantages of the use of this instrumenta-
tion. Nevertheless, using full-scan tandemMS and monitoring multiple fragment ions allowed
us to verify the identity of the major peaks in our experimental samples to authentic standards
by comparison of product ion spectra. In addition, the high concentrations of metabolites pres-
ent in the urine of our dosed animals made the necessary method LODs and LOQs higher than
the typical low ng/mL range found in environmental exposure studies. There was a significant
increase in both signal and quality of the chromatography when using acetic acid versus other
common LC-MS compatible mobile phase additives like formic acid and ammonium formate
or acetate (data not shown). While small amounts of trifluoroacetic acid as a mobile phase ad-
ditive resulted in the best chromatographic resolution, it strongly suppressed ionization in the
Fig 4. Naphthalene metabolite-specific percentages of total quantified metabolite during repeated naphthalene exposure treatments (15 ppm x
4hrs daily) via inhalation.
doi:10.1371/journal.pone.0121937.g004
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negative mode. The targeted metabolites all have highly polar negatively-charged moieties (car-
boxylate, sulfate), thus were easily ionized using negative mode ionization.
Numerous studies measuring 1- and 2-naphthol conjugates in urine of exposed humans
show slightly higher levels of 2-naphthol than 1-naphthol [15,16,25]. In contrast, we were un-
able to detect signals associated with 2-naphtholglucuronide in mouse urine using the 3D trap
instrument. Further analysis of these urine samples using a Thermo Orbitrap XL mass spec-
trometer under identical chromatographic conditions revealed a signal for the 2-naphthol glu-
curonide. Here, the signal for the 2-naphthol derived conjugate was less than 10% of the signal
associated with 1-naphthol glucuronide (data not shown). This is consistent with several of our
earlier studies in mouse lung and liver preparations which show that 2-naphthol is generated at
much slower rates than 1-naphthol (<10%). The underlying basis for these apparent differ-
ences is not clear but may be species-related. In other studies examining the metabolism of
naphthalene in nasal tissues from the rhesus macaques, we have found that the ratio of 2- to
1-naphthol glucuronide is 1:2 (unpublished studies).
Our data (Tables 2 and 3) demonstrate that the method can reliably measure the four tar-
geted urinary naphthalene metabolites with adequate sensitivity and reasonable accuracy and
precision. With the exception of N-acetyl GSH, the metabolites yielded signal at the mid to
high end of the standard curve. Thus, our method can assess metabolite levels of mice exposed
to lower naphthalene levels by adjusting the dilution during sample preparation, though fur-
ther validation studies are needed. The generation of deuterated internal standards biologically
was straightforward and inexpensive and mitigated any excessive matrix effects from both the
urine matrix (-16.8 to 11.8%), and sample preparation (protein precipitation and dilution (86–
101%)).
Earlier work measuring 1- and 2-naphthol levels by GC/MS following enzymatic hydrolysis
in a non-smoking control population reported levels (geometric mean) of these metabolites
that are approximately 100 fold lower than the LOQ’s of the current method [26]. Thus, the
current procedures would require modification to be useful in control human populations ei-
ther through use of larger sample volume (1 ml) or through a more sensitive mass spectrome-
ter. Naphthalene mercapturic acids are easily dehydrated in weak acid to generate the fully
aromatic N-acetyl cysteine derivative of naphthalene so sample recovery from larger urine vol-
umes on a solid phase extraction cartridge would have to properly buffer the solvent used to
elute these metabolites.
The data in Fig 4 show that more than 60% of the metabolites measured in this work were
derived from direct conjugation of naphthalene oxide with glutathione. A very small percent-
age of this total was from an N-acetyl glutathione derivative. This adduct has been reported
previously in both mouse liver perfused with naphthalene and in mouse urine at 0.5 to 3% of a
50 mg/kg naphthalene dose administered intraperitoneally [21], percentages that are very simi-
lar to those reported here following inhalation exposures. The fact that we have not detected
the N-acetyl glutathione derivatives in incubations of airway or nasal epithelial cells suggests
that the excretion of this metabolite in the urine may be a function of metabolism in the liver
followed by acetylation in the kidney. The N-acetyl glutathione metabolite is unusual and we
are unaware of reports showing the elimination of this derivative from other chemicals that un-
dergo metabolic activation.
Mercapturic acids are frequently reported metabolites in human urine derived from either
exposure to exogenous electrophiles or through generation of electrophiles in vivo. These me-
tabolites have proven to be very useful in establishing relationships between the incidence of
lung cancer and exposure to volatile organic carcinogens such as 1,3-butadiene, acrolein and
crotonaldehyde [27] as well determining the possible effectiveness of intervention strategies for
aflatoxin-induced hepatocellular carcinoma [28]. With the exception of presumptive evidence
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showing the isolation of a mercapturic acid in the urine of human volunteers taking a relatively
large dose of naphthalene (500 mg, p.o.), there have been no reports demonstrating the pres-
ence of this metabolite in urine of even relatively heavily exposed individuals such as cigarette
smokers and fuel cell workers. In fact, studies in non-human primates given very large oral
doses of naphthalene (up to 200 mg/kg) showed no increase in thioethers eliminated in the
urine and no detectable depletion of hepatic glutathione levels. Both lung and liver of Rhesus
macaques [29,30] and humans [31,32] metabolize naphthalene to the epoxide albeit at slower
rates than rodents. Whether these rates are too slow to generate detectable amounts of mercap-
turic acid in urine or whether the amounts of epoxide formed are mainly metabolized to the
diol and eliminated as a glucuronide or diglucuronide derivative of remains to be determined.
Adaptation of the method described here provides a useful tool to address these issues.
During the course of the animal exposures, we noted an initial decrease in food and water
intake in the first 2–3 days of exposure followed by increased levels of activity and parallel in-
creases in water and food consumption. This corresponds with a greater than 15% decline in
overall metabolite elimination in days 3 and 4 followed by a dramatic 25–30% increase. The
proportion of the metabolites measured over this time period changed slightly with similar
amounts of glucuronide and sulfate conjugates eliminated but with amounts of mercapturic
acid and N-acetyl glutathione conjugate which increased by more than 40% from the initial lev-
els in the urine. This is consistent with the dramatic increase in γ-glutamyl cysteine synthase
noted in naphthalene tolerant animals [33].
Conclusions
In summary, we present a method for quantitatively measuring 4 of the major naphthalene me-
tabolites eliminated in the urine of mice exposed to naphthalene by inhalation and show that
the most abundant metabolites measured are those arising from direct conjugation of naphtha-
lene oxide with glutathione. In addition to the metabolites measured quantitatively, two other
potentially important metabolites were observed, a diglucuronide of the dihydroxynaphthalene
and N-acetyl cysteine derivatives of the diol epoxide. The unavailability of standards for these
metabolites precluded their quantitative measurement and efforts are underway to prepare
both metabolites synthetically. This method is currently being used to determine metabolite
profiles in rats, where the nasal olfactory and respiratory epithelium plays a far more promi-
nent role in the metabolism of naphthalene and in mEH and GST pi null animals. The method
outlined here should be easily adapted to a triple quadrapole instrument in multiple reaction
monitoring mode with a concomitant decrease in run times and increases in detection
sensitivity.
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